Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Malaria over-diagnosis in Cameroon: diagnostic accuracy of Fluorescence and Staining Technologies (FAST) Malaria Stain and LED microscopy versus Giemsa and bright field microscopy validated by polymerase chain reaction.

Parsel SM, Gustafson SA, Friedlander E, Shnyra AA, Adegbulu AJ, Liu Y, Parrish NM, Jamal SA, Lofthus E, Ayuk L, Awasom C, Henry CJ, McArthur CP.

Infect Dis Poverty. 2017 Apr 4;6(1):32. doi: 10.1186/s40249-017-0251-0.

2.

Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.

Jamal SA, Reid LS, Hamilton CJ.

Osteoporos Int. 2017 Jan;28(1):423. doi: 10.1007/s00198-016-3852-8. No abstract available.

PMID:
27909784
3.

Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.

Jamal SA, Goltzman D, Hanley DA, Papaioannou A, Prior JC, Josse RG.

Osteoporos Int. 2017 Jan;28(1):421. doi: 10.1007/s00198-016-3843-9. No abstract available.

PMID:
27909783
4.

Retraction Notice to "Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study" [Am J Kidney Dis. 55(2):291-299].

Jamal SA, Swan VJD, Brown JP, Hanley DA, Prior JC, Papaioannou A, Langsetmo L, Josse RG; Canadian Multicentre Osteoporosis Study Research Group.

Am J Kidney Dis. 2016 Aug;68(2):333. doi: 10.1053/j.ajkd.2016.06.005. Epub 2016 Jul 21. No abstract available.

PMID:
27477359
5.

Sex hormones, sex hormone binding globulin, and vertebral fractures in older men.

Cawthon PM, Schousboe JT, Harrison SL, Ensrud KE, Black D, Cauley JA, Cummings SR, LeBlanc ES, Laughlin GA, Nielson CM, Broughton A, Kado DM, Hoffman AR, Jamal SA, Barrett-Connor E, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Study Research Group.

Bone. 2016 Mar;84:271-278. doi: 10.1016/j.bone.2016.01.009. Epub 2016 Jan 8.

6.

Bone kidney interactions.

Nickolas TL, Jamal SA.

Rev Endocr Metab Disord. 2015 Jun;16(2):157-63. doi: 10.1007/s11154-015-9314-3. Review.

PMID:
26156535
7.

Fracture Incidence in Adult Kidney Transplant Recipients.

Naylor KL, Jamal SA, Zou G, McArthur E, Lam NN, Leslie WD, Hodsman AB, Kim SJ, Knoll GA, Fraser LA, Adachi JD, Garg AX.

Transplantation. 2016 Jan;100(1):167-75. doi: 10.1097/TP.0000000000000808.

PMID:
26154389
8.

Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease.

Holden RM, Booth SL, Day AG, Clase CM, Zimmerman D, Moist L, Shea MK, McCabe KM, Jamal SA, Tobe S, Weinstein J, Madhumathi R, Adams MA, Heyland DK.

Can J Kidney Health Dis. 2015 May 1;2:17. doi: 10.1186/s40697-015-0053-x. eCollection 2015.

9.

Fractures in chronic kidney disease: pursuing the best screening and management.

Goldenstein PT, Jamal SA, Moysés RM.

Curr Opin Nephrol Hypertens. 2015 Jul;24(4):317-23. doi: 10.1097/MNH.0000000000000131. Review.

PMID:
26050117
10.

Can we compare serum sclerostin results obtained with different assays in hemodialysis patients?

Moysés RM, Jamal SA, Graciolli FG, dos Reis LM, Elias RM.

Int Urol Nephrol. 2015 May;47(5):847-50. doi: 10.1007/s11255-015-0971-7. Epub 2015 Apr 11.

PMID:
25862239
11.

Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report.

Palcu P, Dion N, Ste-Marie LG, Goltzman D, Radziunas I, Miller PD, Jamal SA.

Am J Kidney Dis. 2015 Jun;65(6):933-6. doi: 10.1053/j.ajkd.2015.01.025. Epub 2015 Apr 2.

PMID:
25843705
12.

Vascular calcification in patients with nondialysis CKD over 3 years.

Górriz JL, Molina P, Cerverón MJ, Vila R, Bover J, Nieto J, Barril G, Martínez-Castelao A, Fernández E, Escudero V, Piñera C, Adragao T, Navarro-Gonzalez JF, Molinero LM, Castro-Alonso C, Pallardó LM, Jamal SA.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):654-66. doi: 10.2215/CJN.07450714. Epub 2015 Mar 13.

13.

How to predict and treat increased fracture risk in chronic kidney disease.

West SL, Patel P, Jamal SA.

J Intern Med. 2015 Jul;278(1):19-28. doi: 10.1111/joim.12361. Epub 2015 Apr 16. Review.

14.

Bone imaging and fracture risk assessment in kidney disease.

Jamal SA, Nickolas TL.

Curr Osteoporos Rep. 2015 Jun;13(3):166-72. doi: 10.1007/s11914-015-0262-3. Review.

PMID:
25744703
15.

Comparison of fracture risk prediction among individuals with reduced and normal kidney function.

Naylor KL, Garg AX, Zou G, Langsetmo L, Leslie WD, Fraser LA, Adachi JD, Morin S, Goltzman D, Lentle B, Jackson SA, Josse RG, Jamal SA.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):646-53. doi: 10.2215/CJN.06040614. Epub 2015 Feb 5.

16.

Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.

Ketteler M, Elder GJ, Evenepoel P, Ix JH, Jamal SA, Lafage-Proust MH, Shroff R, Thadhani RI, Tonelli MA, Kasiske BL, Wheeler DC, Leonard MB.

Kidney Int. 2015 Mar;87(3):502-28. doi: 10.1038/ki.2014.425. Epub 2015 Feb 4.

PMID:
25651364
17.

Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis.

Bucur RC, Panjwani DD, Turner L, Rader T, West SL, Jamal SA.

Osteoporos Int. 2015 Feb;26(2):449-58. doi: 10.1007/s00198-014-2813-3. Epub 2014 Dec 5. Review.

PMID:
25477230
18.

Bone mineral density predicts fractures in chronic kidney disease.

West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D, Fusaro M, Wald R, Weinstein J, Jamal SA.

J Bone Miner Res. 2015 May;30(5):913-9. doi: 10.1002/jbmr.2406.

19.

Hyponatremia and Fractures: Findings From the MrOS Study.

Jamal SA, Arampatzis S, Harrison SL, Bucur RC, Ensrud K, Orwoll ES, Bauer DC.

J Bone Miner Res. 2015 Jun;30(6):970-5. doi: 10.1002/jbmr.2383.

20.

The interpretation and utility of bone mineral density by dual energy X-ray absorptiometry in chronic kidney disease.

West SL, Jamal SA.

Semin Dial. 2014 Nov-Dec;27(6):569-71. doi: 10.1111/sdi.12267. Epub 2014 Jun 27. No abstract available.

PMID:
24976496
21.

The clinical characteristics of patients with hip fractures in typical locations and atypical femoral fractures.

Velasco S, Kim S, Bleakney R, Jamal SA.

Arch Osteoporos. 2014;9:171. doi: 10.1007/s11657-014-0171-6. Epub 2014 Jan 31.

PMID:
24481776
22.

The three-year incidence of fracture in chronic kidney disease.

Naylor KL, McArthur E, Leslie WD, Fraser LA, Jamal SA, Cadarette SM, Pouget JG, Lok CE, Hodsman AB, Adachi JD, Garg AX.

Kidney Int. 2014 Oct;86(4):810-8. doi: 10.1038/ki.2013.547. Epub 2014 Jan 15.

23.

Organic nitrates for osteoporosis: an update.

Hamilton CJ, Reid LS, Jamal SA.

Bonekey Rep. 2013 Feb 6;2:259. doi: 10.1038/bonekey.2012.259.

24.

Fractures in chronic kidney disease: neglected, common, and associated with sickness and death.

Fusaro M, Gallieni M, Jamal SA.

Kidney Int. 2014 Jan;85(1):20-2. doi: 10.1038/ki.2013.302.

25.
26.

Tumour induced osteomalacia due to a sinonasal hemangiopericytoma: A case report.

Jamal SA, Dickson BC, Radziunas I.

World J Clin Cases. 2013 Apr 16;1(1):59-63. doi: 10.12998/wjcc.v1.i1.59.

27.

Osteoprotegerin and fractures in men and women with chronic kidney disease.

West SL, Lok CE, Jamal SA.

J Bone Miner Metab. 2014 Jul;32(4):428-33.

PMID:
24122248
28.

The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Jamal SA, West SL, Nickolas TL.

Osteoporos Int. 2014 Jan;25(1):71-6. doi: 10.1007/s00198-013-2524-1. Epub 2013 Oct 11.

PMID:
24114399
29.

Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial.

Bucur RC, Reid LS, Hamilton CJ, Cummings SR, Jamal SA.

Trials. 2013 Sep 8;14:284. doi: 10.1186/1745-6215-14-284.

30.

Renal safety in patients treated with bisphosphonates for osteoporosis: a review.

Miller PD, Jamal SA, Evenepoel P, Eastell R, Boonen S.

J Bone Miner Res. 2013 Oct;28(10):2049-59. doi: 10.1002/jbmr.2058. Review.

31.

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT.

Lancet. 2013 Oct 12;382(9900):1268-77. doi: 10.1016/S0140-6736(13)60897-1. Epub 2013 Jul 19. Review.

PMID:
23870817
32.

Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: insight into the BMD and bone fragility paradox.

Hamilton CJ, Jamal SA, Beck TJ, Khaled AS, Adachi JD, Brown JP, Davison KS; Canadian Multicentre Osteoporosis Study (CaMos) Research Group.

Metabolism. 2013 Oct;62(10):1401-5. doi: 10.1016/j.metabol.2013.05.004. Epub 2013 Jun 13.

PMID:
23768546
33.

Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos).

Langsetmo L, Berger C, Kreiger N, Kovacs CS, Hanley DA, Jamal SA, Whiting SJ, Genest J, Morin SN, Hodsman A, Prior JC, Lentle B, Patel MS, Brown JP, Anastasiades T, Towheed T, Josse RG, Papaioannou A, Adachi JD, Leslie WD, Davison KS, Goltzman D; CaMos Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):3010-8. doi: 10.1210/jc.2013-1516. Epub 2013 May 23.

34.

Fracture risk in kidney transplant recipients: a systematic review.

Naylor KL, Li AH, Lam NN, Hodsman AB, Jamal SA, Garg AX.

Transplantation. 2013 Jun 27;95(12):1461-70. doi: 10.1097/TP.0b013e31828eead8. Review.

PMID:
23594857
35.

Heterogeneity in skeletal load adaptation points to a role for modeling in the pathogenesis of osteoporotic fracture.

Hamilton CJ, Jamal SA, Beck TJ, Khaled AS, Adachi JD, Brown JP, Davison KS; Canadian Multicentre Osteoporosis Study (CaMos) Research Group.

J Clin Densitom. 2014 Jan-Mar;17(1):170-6. doi: 10.1016/j.jocd.2013.02.003. Epub 2013 Mar 9.

PMID:
23478079
36.

The effects of organic nitrates on osteoporosis: a systematic review.

Jamal SA, Reid LS, Hamilton CJ.

Osteoporos Int. 2013 Mar;24(3):763-70. doi: 10.1007/s00198-012-2262-9. Epub 2013 Jan 11. Review.

PMID:
23306823
37.

Secondary and tertiary hyperparathyroidism.

Jamal SA, Miller PD.

J Clin Densitom. 2013 Jan-Mar;16(1):64-8. doi: 10.1016/j.jocd.2012.11.012. Epub 2012 Dec 23. Review.

PMID:
23267748
38.

Calcium builds strong bones, and more is better--correct? Well, maybe not.

Jamal SA, Moe SM.

Clin J Am Soc Nephrol. 2012 Nov;7(11):1877-83. doi: 10.2215/CJN.04880512. Epub 2012 Jul 26. Review.

39.

The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).

Targownik LE, Leslie WD, Davison KS, Goltzman D, Jamal SA, Kreiger N, Josse RG, Kaiser SM, Kovacs CS, Prior JC, Zhou W; CaMos Research Group.

Am J Gastroenterol. 2012 Sep;107(9):1361-9. doi: 10.1038/ajg.2012.200. Epub 2012 Jul 10. Erratum in: Am J Gastroenterol. 2013 Jan;108(1):157.

40.

Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease.

West SL, Jamal SA.

Semin Dial. 2012 Jul;25(4):397-402. doi: 10.1111/j.1525-139X.2012.01096.x. Epub 2012 Jun 11. Review.

PMID:
22686655
41.

Bone and kidney disease: diagnostic and therapeutic implications.

Jamal SA, West SL, Miller PD.

Curr Rheumatol Rep. 2012 Jun;14(3):217-23. doi: 10.1007/s11926-012-0243-9. Review.

PMID:
22350608
42.

Nutrition: calcium and vitamin D for extraskeletal health--jury is out.

Velasco S, Jamal SA.

Nat Rev Endocrinol. 2012 Jan 31;8(3):132-3. doi: 10.1038/nrendo.2012.10. No abstract available.

PMID:
22290356
43.

Nitric oxide donors for the treatment of osteoporosis.

Jamal SA, Hamilton CJ.

Curr Osteoporos Rep. 2012 Mar;10(1):86-92. doi: 10.1007/s11914-011-0087-7. Review.

PMID:
22210559
44.

Tests of neuromuscular function are associated with fractures in patients with chronic kidney disease.

West SL, Jamal SA, Lok CE.

Nephrol Dial Transplant. 2012 Jun;27(6):2384-8. doi: 10.1093/ndt/gfr620. Epub 2011 Nov 18.

PMID:
22102617
45.

Atypical femoral fractures and bone turnover.

Jamal SA, Dion N, Ste-Marie LG.

N Engl J Med. 2011 Sep 29;365(13):1261-2. doi: 10.1056/NEJMc1107029. No abstract available.

PMID:
21991914
46.

Fracture risk assessment in patients with chronic kidney disease.

Jamal SA, West SL, Miller PD.

Osteoporos Int. 2012 Apr;23(4):1191-8. doi: 10.1007/s00198-011-1781-0. Epub 2011 Sep 8. Review.

PMID:
21901475
47.

Topical nitrates for osteoporosis: a cheap future direction?

Jamal SA, Hamilton CJ.

Maturitas. 2011 Oct;70(2):97-8. doi: 10.1016/j.maturitas.2011.06.016. Epub 2011 Jul 30. No abstract available.

PMID:
21803514
48.

Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(®): a population-based report from CAMOS.

Leslie WD, Kovacs CS, Olszynski WP, Towheed T, Kaiser SM, Prior JC, Josse RG, Jamal SA, Kreiger N, Goltzman D; CaMos Research Group.

J Clin Densitom. 2011 Jul-Sep;14(3):286-93. doi: 10.1016/j.jocd.2011.04.011. Epub 2011 Jul 1.

49.

Effects of denosumab on fracture and bone mineral density by level of kidney function.

Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD.

J Bone Miner Res. 2011 Aug;26(8):1829-35. doi: 10.1002/jbmr.403.

50.

Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.

Jamal SA, Hamilton CJ, Eastell R, Cummings SR.

JAMA. 2011 Feb 23;305(8):800-7. doi: 10.1001/jama.2011.176. Retraction in: Eastell R, Hamilton CJ, Cummings SR. JAMA. 2016 Jan 26;315(4):418-9.

PMID:
21343579

Supplemental Content

Loading ...
Support Center